Brigitte Poirier

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2011 · 2.4K citations

Medicine, Oncology, Pharmacology +16

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial

Luca Gianni, Tadeusz Pieńkowski, Young‐Hyuck Im et al. · The Lancet Oncology · 2016 · 874 citations

Medicine, Immunology, Oncology +17

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Jean-François Boileau, Brigitte Poirier, Mark Basik et al. · Journal of Clinical Oncology · 2014 · 842 citations

Medicine, Oncology, Breast Oncology +16

Determinants of gastrointestinal complications in cardiac surgery.

Giuseppe D’Ancona, Richard Baillot, Brigitte Poirier et al. · PubMed · 2003 · 134 citations · Full text

Medicine, Cardiology, Surgery +14

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial

Giampaolo Bianchini, Lajos Pusztai, Tadeusz Pieńkowski et al. · Annals of Oncology · 2015 · 134 citations

Medicine, Immunology, Oncology +17